Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Pain Relief & OTC Medication Recalls

Recalls of common over-the-counter and prescription pain relievers.

415 recalls in this category, newest first.

Class II · Moderate risk

Pain Reliever

Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity.

Completed Impurity / degradation Aurobindo Pharma USA Inc. NDC 0363-9947-35 D-0765-2023
Class III · Low risk

Gabapentin Tablets

Product mixup: one foreign tablet found in product.

Terminated Labeling / mix-up The Harvard Drug Group NDC 0904-6823-61 D-0570-2023
Class III · Low risk

Gabapentin Tablets

Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.

Terminated Particulate / foreign matter Sciegen Pharmaceuticals Inc D-0354-2023
Class I · High risk

Advil Liqui Gels

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Terminated Labeling / mix-up Glaxosmithkline Consumer Healthcare Holdings DBA Haleon D-0183-2023
Class I · High risk

Advil Liqui Gels

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Terminated Labeling / mix-up Glaxosmithkline Consumer Healthcare Holdings DBA Haleon D-0182-2023
Class I · High risk

Advil (ibuprofen)

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Terminated Labeling / mix-up Glaxosmithkline Consumer Healthcare Holdings DBA Haleon D-0181-2023
Class II · Moderate risk

Acetaminophen Injection

Temperature Abuse: Product distributed in refrigerated trucks with labels attached to pallets indicating "Refrigerate Upon Arrival", however product is labeled to be stored in a controlled room temperature environment.

Terminated Temperature excursion Baxter Healthcare Corporation NDC 36000-306-60 D-1348-2022
Class III · Low risk

Zynrelef (bupivacaine and meloxicam)

Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit

Terminated Packaging defect Heron Therapeutics, INC. NDC 47426-301-02 D-1335-2022
Class II · Moderate risk

Acetaminophen Oral Solution 650 mg / 20.3 mL

CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Terminated cGMP deviation Plastikon Healthcare LLC NDC 0904-6820-76 D-1486-2022
Class II · Moderate risk

Acetaminophen Oral Solution

CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Terminated cGMP deviation Plastikon Healthcare LLC NDC 0904-6739-71 D-1485-2022
Class II · Moderate risk

Acetaminophen Oral Solution 160 mg / 5 mL

CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.

Terminated cGMP deviation Plastikon Healthcare LLC NDC 0904-6738-70 D-1484-2022